Qube Research & Technologies LTD Gamida Cell Ltd. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.04 - $0.46 $1,605 - $18,464	-40,141 Reduced 11.88%	297,812 $11,000
Q4 2023 Feb 13, 2024	BUY	$0.25 - $1.02 $76,141 - $310,658	304,567 Added 912.26%	337,953 $138,000
Q3 2023 Nov 13, 2023	BUY	$0.85 - $1.87 $28,378 - $62,431	33,386 New	33,386 $34,000
Q3 2021 Nov 12, 2021	SELL	$3.85 - $6.44 $158,235 - $264,684	-41,100 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$5.85 - $8.33 $146,665 - $208,841	25,071 Added 156.41%	41,100 $263,000
Q1 2021 May 14, 2021	BUY	$7.8 - $12.43 $125,026 - $199,240	16,029 New	16,029 $130,000

2.2K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.